Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status:
Completed
Trial end date:
2017-03-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether a controlled release formulation of
mazindol is more effective than a placebo in the treatment of Attention Hyperactivity
Disorder (ADHD) in adults.